Cloning of the human platelet F11 receptor: A cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation

Blood

Volumn 95, Issue 8, 2000, Pages 2600-2609

  Sobocka, Malgorzata B ^b   Sobocki, Tomasz ^b   Banerjee, Probal ^b   Weiss, Cipora ^b   Rushbrook, Julie I ^b   Norin, Allen J ^b   Hartwig, John ^b   Salifu, Moro O ^b   Markell, Mariana S ^b   Babinska, Anna ^b   Ehrlich, Yigal H ^b   Kornecki, Elizabeth ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; COLLAGEN; COMPLEMENTARY DNA; FIBRINOGEN RECEPTOR; IMMUNOGLOBULIN CLASS; RECEPTOR ANTIBODY; THROMBIN; THROMBOCYTE RECEPTOR;

ARTICLE; CELLULAR DISTRIBUTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

EID: 0034655579     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.8.2600     Document Type: Article

References (64)

1. Kelton JG. The serological investigation of patients with autoimmune thrombocytopenia. Thromb Haemost. 1995;74:228-233.
2. Bussel JB, Schreiber AD. Immune thrombocytopenic purpura, neonatal alloimmune thrombocytopenia, and posttransfusion purpura. In: Hematology: Basic Principles and Practice. Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, eds. New York: Churchill Livingstone; 1999.
3. McMillan R, Tani P, Millard F, Berchtold P, Renshaw L, Woods VL Jr. Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood. 1987;70:1040-1045.
4. Taub JW, Warrier I, Holtkamp C, Beardsley DS, Lusher JM. Characterization of autoantibodies against the platelet glycoprotein antigens IIb/IIIa in childhood idiopathic thrombocytopenia purpura. Am J Hematol. 1995;48:104-107.
5. Woods VL Jr, Kurata Y, Montgomery RR, et al. Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura Blood. 1984;84:156-160.
6. Woods VL Jr, Oh EH, Mason D, McMillan R. Autoantibodies against the platelet glycoprotein IIb/ IIIa in patients with chronic ITP. Blood. 1984;63: 368-375.
7. Yanabu M, Nomura S, Fukuroi T, et al. Platelet activation induced by an antiplatelet autoantibody against CD9 antigen and its inhibition by another autoantibody in immune thrombocytopenic purpura. Br J Haematol. 1993;84:694-701.
8. Yanabu M, Nomura S, Fukuroi T, et al. Synergistic action in platelet activation induced by an anti-platelet autoantibody in ITP. Br J Haematol. 1991; 78:87-93.
9. Yanabu M, Suzuki M, Soga T, et al. Influences of antiplatelet antibodies on platelet function in immune thrombocytopenic purpura. Eur J Haematol. 1991;46:101-106.
10. Bierling P, Bettaieb A, Oksenhendler E. Human immunodeficiency virus-related immune thrombocytopenia. Semin Thromb Hemost. 1995;21:68-75.
11. Bettaieb A, Fromont P, Louache F. Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura. Blood. 1992;80:162-169.
12. Aiken ML, Ginsberg MH, Byers-Ward V, Plow EF. Effects of OKM5, a monoclonal antibody to glycoprotein IV, on platelet aggregation and thrombospondin surface expression. Blood. 1990;76: 2501-2509.
13. Anderson GP, van de Winkel JG, Anderson CL. Anti-GPIIb/IIIa (CD41) monoclonal antibody-induced platelet activation requires Fc receptor-dependent cell-cell interaction. Br J Haematol. 1991;79:75-83.
14. Bachelot C, Rendu F, Boucheix C, Hogg N, Levy-Toledano S. Activation of platelets induced by mAb P256 specific for glycoprotein IIb-IIIa: possible evidence for a role for IIb-IIIa in membrane signal transduction. Eur J Biochem. 1990;190: 177-183.
15. Hornby EJ, Brown S, Wilkinson JM, Mattock C, Authi KS. Activation of human platelets by exposure to a monoclonal antibody, PM6/248, to glycoprotein IIb-IIIa. Br J Haematol. 1991;79:277-285.
16. Jennings LK, Fox CF, Kouns WC, McKay CP, Ballou LR, Schultz HE. The activation of human platelets mediated by anti-human platelet p24/ CD9 monoclonal antibodies. J Biol Chem. 1990; 265:3815-3822.
17. Modderman PW, Huisman HG, van Mourik JA, von dem Borne AE. A monoclonal antibody to the human platelet glycoprotein IIb/IIIa complex induces platelet activation. Thromb Haemost. 1988; 60:68-74.
18. Morel MC, Lecompte T, Champeix P, et al. PL2-49, a monoclonal antibody against glycoprotein llb which is a platelet activator. Br J Haematol. 1989;71:57-63.
19. Shah VO, Zamora PO, Mills SL, Mann PL, Comp PC. In vitro studies with the platelet-reactive antibody 50H.19 and its fragments. Thromb Res. 1990;58:493-504.
20. Testi R, Pulcinelli F, Frati L, Gazzaniga PP, Santoni A. CD69 is expressed on platelets and mediates platelet activation and aggregation. J Exp Med. 1990;172:701-707.
21. Kornecki E, Cooper BA, Ehrlich YH. Identification of a unique type of thrombopathy of human platelets: defect in the exposure of active fibrinogen receptors in a patient with Friedreich's ataxia. J Lab Clin Med. 1988;111:618-626.
22. Kornecki E, Walkowiak B, Naik UP, Ehrlich YH. Activation of human platelets by a stimulatory monoclonal antibody. J Biol Chem. 1990;265: 10,042-10,048.
23. Naik UP, Ehrlich YH, Kornecki E. Mechanisms of platelet activation by a stimulatory antibody: cross-linking of a novel platelet receptor for mAb F11 with the FcγR11 receptor. Biochem J. 1995; 310:155-162.
24. Wang F, Naik UP, Ehrlich YH, Osada S-I, Ohno S, Kornecki E. Stimulatory antibody-induced activation and selective translocation of protein kinase C isoenzymes in human platelets. Biochem J. 1995;311:401-406.
25. Kornecki E, Naik UP, Sobocka M, Ehrlich YH. Mechanisms of stimulation and inhibition of platelet activation by monoclonal antibodies. In: Leucocyte Typing V. Schlossman SF et al, eds. Oxford: Oxford University Press; 1995;1241-1243.
26. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and lumour promotion. Nature. 1986;308:693-698.
27. Daniel JL, Molish IR, Rigmaiden M, Stewart G. Role of myosin phosphorylation in the initiation of the platelet shape change. J Biol Chem. 1984; 259:9826-9831.
28. Schwoch G, Passow H. Preparation and properties of human erythrocyte ghosts. Mol Cell Biochem. 1973;2:197-218.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
30. Sambrook J, Fritch EF, ManiatisT. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
31. Kozak M. An analysis of 5-noncoding sequences from 699 vertebrate RNAs. Nucl Acid Res. 1987; 15:8125-8148.
32. Kozak M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol. 1987;196:947-950.
33. Bjellqvist B, Hughes GJ, Pasquali CH, et al. The focusing positions of polypeptides in immobilized pH gradients can be predicted from their amino acid sequences. Electrophoresis. 1993;14:1023-1031.
34. Bjellqvist B, Basse B, Olsen E , Celis JE. Reference points for comparisons of two-dimensional maps ol proteins from different human cell types defined in a pH scale where isoelectric points correlate with polypeptide compositions. Electrophoresis. 1994;15:529-539.
35. Nielsen H, Engelbrecht J, Brunak S, von Heijne G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 1997;10:1-6.
36. Singer SJ. The structure and insertion of integral proteins in membranes. Ann Rev Cell Biol. 1990; 6:247-296.
37. Bause E. Structural requirements of N-glycosylation of proteins: studies with proline peptides as conformational probes. Biochem J. 1983;209: 331-336.
38. Gavel Y, von Heijne G. Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering. Protein Eng. 1990;3:433-442.
39. Miletich JP, Braze GJ Jr. Beta protein C is not glycosylated at asparagine 329: the rate of translation may influence the frequency of usage at asparagine-X-cysteine sites. J Biol Chem. 1990;265: 11,397-11,404.
40. Pinna L. Casein kinase 2: an "eminence grise" in cellular regulation? Biochim Biophys Acta. 1990; 1054:267-284.
41. Woodget JR, Gould KL, Hunter T. Substrate specificity of protein kinase C: use of synthetic peptides corresponding to physiological sites as probes for substrate recognition requirements. Eur J Biochem. 1986;161:177-184.
42. Kishimoto A, Nishiyama K, Nakanishi H, et al. Studies on the phosphorylation of myelin basic protein by protein kinase C and adenosine 3′:5′-monophosphate-dependent protein kinase. J Biol Chem. 1985;260:12,492-12,499.
43. Glass DB, Smith SB. Phosphorylation by cyclic GMP-dependent protein kinase of a synthetic peptide corresponding to the autophosphorylation site in the enzyme. J Biol Chem. 1983;258: 14,797-14,803.
44. Glass DB, El-Maghrabi MR, Pilkis SJ. Synthetic peptides corresponding to the site phosphorylated in 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as substrates of cyclic nucleotide-dependent protein kinases. J Biol Chem. 1986;261:2987-2993.
45. Naik UP, Kornecki E, Ehrlich YH. Phosphorylation of human platelet surface proteins by an ecto-protein kinase system: association with a platelet surface ecto-protein phosphatase. Biochim Biophys Acta. 1991;1092:256-264.
46. Babinska A, Ehrlich YH, Kornecki E. Activation of human platelets by protein kinase antibody for surface phosphorylation: role in homeostasis. Am J Physiol. 1996;271:H2134-H2144.
47. Babinska A, Hogan MV, Sobocki T, Sobocka MB, Ehrlich YH, Komecki E. Identification of ecto-PKC on the surface of human platelets: role in the maintenance of latent fibrinogen receptors. Am J Physiol. In press.
48. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982;157:105-132.
49. Williams AF, Barclay N. The immunoglobulin superfamily: domains for cell surface recognition. Ann Rev Immunol. 1988;6:381-405.
50. Williams AF, Davis SJ, He Q, Barclay AN. Structural diversity in domains of the immunoglobulin superfamily. Cold Spring Harb Symp Quant Biol. 1989;54(pt 2):537-647.
51. Bork P, Holm L, Sander C. The immunoglobulin fold. J Mol Biol. 1994;242:309-312.
52. Bruemmendorf T, Rathjen FG. Cell adhesion molecules, 1. Protein Profile. 1995;2:963-1108.
53. Karplus K, Sjolander K, Barren C, et al. Predicting protein structure using hidden Markov models. Proteins. 1997;1(suppl):134-139.
54. Schultz J, Milpetz F, Bork P, Ponting CP. SMART, a simple modular architecture research tool: identification of signaling domains, Proc Natl Acad Sci U S A. 1998;95:5857-5864.
55. Ginsberg MH, Du X, Plow EF. Inside-out integrin signalling. Curr Opin Cell Biol. 1992;4:756-771.
56. Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol. 1993;120:577-585.
57. Schwanz MA. Transmembrane signalling by integrins. Trends Cell Biol. 1992;2:304.
58. Vassbotn FS, Havnen OK, Heldin CH, Holmsen H. Negative feedback regulation of human platelets via autocrine activation of the platelet-derived growth factor alpha-receptor. J Biol Chem. 1994; 269:13,874-13,879.
59. Van Mourik JA, Leeksma OC, Reinders JH, de Groot PG, Zandbergen-Spaargaren J, Vascular endothelial cells synthesize a plasma membrane protein indistinguishable from the platelet membrane glycoprotein IIa. J Biol Chem. 1985;260: 11,300-11,306.
60. Martin-Padura I, Lostaglio S, Schneemann M, et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol.1998;142: 117-127.
61. Welt S, Divgi CR, Real FX, et al. Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33. J Clin Oncol.1990;8:1894-1906.
62. Heath JK, White SJ, Johnstone CN, et al. The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily. Proc Natl Acad Sci U S A. 1997; 94:469-474.
63. Moritz RL, Ritter G, Catimel B, et al. Microsequencing strategies for the human A33 antigen, a novel surface glycoprotein of human gastrointestinal epithelium. J Chromatogr.1998;798: 91-101.
64. Ozaki H, Ishii K, Horiuchi H, et al. Combined treatment of TNF-a and IFN-g causes redistribution of junctional adhesion molecule in human endothelial cells. J Immunol. 1999;163: 553-557.